Hess DM - Search Results

1

FcR interactions do not play a major role in inhibition of experimental autoimmune encephalomyelitis by anti-CD154 monoclonal antibodies.

Nagelkerken L, Haspels I, van Rijs W, Blauw B, Ferrant JL, Hess DM, Garber EA, Taylor FR, Burkly LC. Nagelkerken L, et al. Among authors: hess dm. J Immunol. 2004 Jul 15;173(2):993-9. doi: 10.4049/jimmunol.173.2.993. J Immunol. 2004. PMID: 15240687

2

Variation in the ordered structure of complexes between CD154 and anti-CD154 monoclonal antibodies.

Ferrant JL, Wilson CA, Benjamin CD, Hess DM, Hsu YM, Karpusas M, Roux KH, Taylor FR. Ferrant JL, et al. Among authors: hess dm. Mol Immunol. 2002 Sep;39(1-2):77-84. doi: 10.1016/s0161-5890(02)00045-7. Mol Immunol. 2002. PMID: 12213330

3

The contribution of Fc effector mechanisms in the efficacy of anti-CD154 immunotherapy depends on the nature of the immune challenge.

Ferrant JL, Benjamin CD, Cutler AH, Kalled SL, Hsu YM, Garber EA, Hess DM, Shapiro RI, Kenyon NS, Harlan DM, Kirk AD, Burkly LC, Taylor FR. Ferrant JL, et al. Among authors: hess dm. Int Immunol. 2004 Nov;16(11):1583-94. doi: 10.1093/intimm/dxh162. Epub 2004 Oct 5. Int Immunol. 2004. PMID: 15466914

4

Anti-CD154 (CD40L) prevents recurrence of diabetes in islet isografts in the DR-BB rat.

Kover KL, Geng Z, Hess DM, Benjamin CD, Moore WV. Kover KL, et al. Among authors: hess dm. Diabetes. 2000 Oct;49(10):1666-70. doi: 10.2337/diabetes.49.10.1666. Diabetes. 2000. PMID: 11016450

5

Prevention of autoimmune diabetes in the DRBB rat by CD40/154 blockade.

Moore WV, Chu W, Tong PY, Hess D, Benjamin C, Khalili J, Kover K. Moore WV, et al. J Autoimmun. 2002 Nov;19(3):139-45. doi: 10.1006/jaut.2002.0605. J Autoimmun. 2002. PMID: 12419284

6

Intragraft gene and protein expression in rat liver allografts treated with costimulatory blockade alone or in combination with CyA.

Bartlett AS, McCall JL, Ameratunga R, Howden B, Ramadas R, Yeong ML, Benjamin CD, Hess D, Munn SR. Bartlett AS, et al. J Surg Res. 2003 Nov;115(1):1-8. doi: 10.1016/s0022-4804(03)00131-8. J Surg Res. 2003. PMID: 14572766

7

Pharmacokinetics/dynamics of 5c8, a monoclonal antibody to CD154 (CD40 ligand) suppression of an immune response in monkeys.

Gobburu JV, Tenhoor C, Rogge MC, Frazier DE Jr, Thomas D, Benjamin C, Hess DM, Jusko WJ. Gobburu JV, et al. Among authors: hess dm. J Pharmacol Exp Ther. 1998 Aug;286(2):925-30. J Pharmacol Exp Ther. 1998. PMID: 9694951

8

Localization of TrkC to Schwann cells and effects of neurotrophin-3 signaling at neuromuscular synapses.

Hess DM, Scott MO, Potluri S, Pitts EV, Cisterni C, Balice-Gordon RJ. Hess DM, et al. J Comp Neurol. 2007 Apr 1;501(4):465-82. doi: 10.1002/cne.21163. J Comp Neurol. 2007. PMID: 17278135

9

Neurotrophin and Trk-mediated signaling in the neuromuscular system.

Pitts EV, Potluri S, Hess DM, Balice-Gordon RJ. Pitts EV, et al. Among authors: hess dm. Int Anesthesiol Clin. 2006 Spring;44(2):21-76. doi: 10.1097/00004311-200604420-00004. Int Anesthesiol Clin. 2006. PMID: 16849956 Review. No abstract available.

10

Treatment of autoimmune hyperthyroidism in a murine model of Graves' disease with tumor necrosis factor-family ligand inhibitors suggests a key role for B cell activating factor in disease pathology.

Gilbert JA, Kalled SL, Moorhead J, Hess DM, Rennert P, Li Z, Khan MZ, Banga JP. Gilbert JA, et al. Among authors: hess dm. Endocrinology. 2006 Oct;147(10):4561-8. doi: 10.1210/en.2006-0507. Epub 2006 Jun 22. Endocrinology. 2006. PMID: 16794009

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page